# NKT THERAPEUTICS INC — Form D

NKT THERAPEUTICS INC of WALTHAM, MA, a company, filed a Form D exempt-offering notice with the SEC on 2010-08-24. The offering totals $4.0M, of which $4.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2010-08-24
- Form: D
- Accession: 0000897069-10-000521
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $4.0M
- Amount sold: $4.0M
- Remaining: $1
- Minimum investment: $10K
- Investors: 3
- Date of first sale: 2010-08-10
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-146851

## Issuer

- Name: NKT THERAPEUTICS INC
- CIK: 0001452964
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2008
- Address: 1000 WINTER STREET, WALTHAM, MA, 02451
- Phone: 781-684-0290

## Officers, directors & promoters (7)

| Name | Role | Location |
| --- | --- | --- |
| David J Hung, M.D. | Director | Waltham, MA |
| Maggie J LeFlore, Ph.D. | Director | Waltham, MA |
| Robert Mashal, M.D. | Director | Waltham, MA |
| Michael J Ross, Ph.D. | Director | Waltham, MA |
| Robert Mashal, M.D. | Executive Officer | Waltham, MA |
| Alemseged Truneh, Ph.D. | Executive Officer | Waltham, MA |
| Robert Mashal, M.D. | Promoter | Waltham, MA |

## More

- [CIK 1452964 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1452964&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0000897069-10-000521.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.